Maccura Biotechnology Co Ltd
SZSE:300463
Maccura Biotechnology Co Ltd
Cash from Operating Activities
Maccura Biotechnology Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Maccura Biotechnology Co Ltd
SZSE:300463
|
Cash from Operating Activities
¥856.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Operating Activities
¥13.4B
|
CAGR 3-Years
50%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Operating Activities
¥2.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Operating Activities
¥6.8B
|
CAGR 3-Years
54%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
17%
|
CAGR 10-Years
31%
|
|
Genscript Biotech Corp
HKEX:1548
|
Cash from Operating Activities
-$245.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Maccura Biotechnology Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
856.2m
CNY
Based on the financial report for Sep 30, 2023, Maccura Biotechnology Co Ltd's Cash from Operating Activities amounts to 856.2m CNY.
What is Maccura Biotechnology Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
50%
Over the last year, the Cash from Operating Activities growth was -36%. The average annual Cash from Operating Activities growth rates for Maccura Biotechnology Co Ltd have been 5% over the past three years , 50% over the past five years .